Teva Resolves Glaxo IP Suit Over Generic Combivir
Magistrate Judge Leonard P. Stark of the U.S. District Court for the District of Delaware dismissed the case Wednesday, though terms of the deal were not disclosed. Attorneys for the companies could not be reached for comment Thursday.
Teva had planned to launch a generic version earlier in May, and Glaxo had asked the...
To view the full article, register now.